NCT06374017View on ClinicalTrials.gov

Evaluation of Lidocaine Spray Versus Dexmetomidine Spray on Stress Response

PHASE4CompletedINTERVENTIONAL

Enrollment

120

Participants

Timeline

Start Date

April 20, 2024

Primary Completion Date

December 30, 2024

Study Completion Date

January 10, 2025

Conditions

To Measure Systolic Blood Pressure Postintubation

Interventions

DRUG

Normal saline, Lidocaine, dexmetomidine

The study drug of each group will be sprayed into oropharynx, the vocal cords and tracheal tree 3 minutes after induction of anesthesia and 5 minutes before intubation.

Trial Locations (1)

11559

Cairo University hospitals, Cairo

All Listed Sponsors

lead

Kasr El Aini Hospital

OTHER

NCT06374017 - Evaluation of Lidocaine Spray Versus Dexmetomidine Spray on Stress Response | Biotech Hunter | Biotech Hunter